143 related articles for article (PubMed ID: 8934732)
21. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
[TBL] [Abstract][Full Text] [Related]
22. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
Peiffert D
Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
[TBL] [Abstract][Full Text] [Related]
23. [Neoadjuvant treatment of operable esophageal cancers].
Azria D; Ychou M; Senesse P; Dubois JB
Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
[No Abstract] [Full Text] [Related]
24. [Preliminary clinical evaluation of continuous infusion of 5-FU and low-dose Cisplatin (LFP) therapy alone and combined with radiation therapy for treatment of advanced or recurrent esophageal cancer].
Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
Gan To Kagaku Ryoho; 2002 Feb; 29(2):233-8. PubMed ID: 11865629
[TBL] [Abstract][Full Text] [Related]
25. [A case of advanced esophageal carcinoma successfully treated with chemoradiation therapy with low-dose cisplatin and 5-fluorouracil].
Oyama K; Hirosawa H; Ito H; Fukushima W; Masutani H; Kadoya N; Izumi R; Hirono T
Gan To Kagaku Ryoho; 2000 Jun; 27(6):899-903. PubMed ID: 10897218
[TBL] [Abstract][Full Text] [Related]
26. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
27. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
29. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
Delouche D; Haefliger JM
Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
[No Abstract] [Full Text] [Related]
30. [Phase I study of CM-Na combined with concurrent radiochemotherapy for advanced esophageal carcinoma].
Cai L; Liu MZ; Gu MF; Liu H; Chen EC; Hu YH; Lin HX; Wang HY; Huang Y; Li QQ; Cui NJ; Rong TH
Ai Zheng; 2005 May; 24(5):582-6. PubMed ID: 15890102
[TBL] [Abstract][Full Text] [Related]
31. [Antiblastic treatment in metastatic colorectal cancer].
Mustacchi G; Milani S
Ann Ital Chir; 1992; 63(3):333-6. PubMed ID: 1280019
[No Abstract] [Full Text] [Related]
32. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
34. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
35. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
36. RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?
Herman JM; Thomas CR
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):8-10. PubMed ID: 23582245
[No Abstract] [Full Text] [Related]
37. [Radio- and chemotherapy of cancer of the esophagus].
Tiret E
Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
[TBL] [Abstract][Full Text] [Related]
38. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
Grünberger B; Raderer M; Schmidinger M; Hejna M
Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
[TBL] [Abstract][Full Text] [Related]
39. [Concurrent chemoradiotherapy update].
Reboul F; Vincent P; Chauvet B; Alfonsi M; Berger C; Serin D
Bull Cancer; 1999 Jan; 86(1):77-83. PubMed ID: 10029709
[No Abstract] [Full Text] [Related]
40. [Progress of postoperative adjuvant therapies for esophageal cancer].
Terashima M; Kogure M; Gotoh M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2475-80. PubMed ID: 12506469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]